DoW Parkinson’s, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Опубликован 18 июн. 2026 г. · Осталось 29 дней
Простыми словами
Краткое описание на русском пока недоступно; показано на английском.
The US Defense Health Agency funds rigorous, multidisciplinary research projects addressing Parkinson's disease through its fiscal year 2026 research programme. Any entity type may apply if based in the United States, with awards from a 10 million dollar total pool, and applications are due by 6 November 2026.
Автоматическое краткое изложение текста донора; оригинальная формулировка приведена ниже.
Краткое описание
Исходный текст донора (английский)
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research. Research must address at least one of the four FY26 PRP Focus Areas.
Distinctive Features:
· Partnering Principal Investigator (PI) Option: Allows for more than one PI. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI(s) will be identified as Partnering PI(s), with a maximum of two Partnering PIs.
· Preliminary data are required.
· Clinical trials are allowed.
Фрагмент со страницы донора. Полный текст, приложения и формы — в исходном объявлении о конкурсе.
Кто может подать заявку
- Академическое или исследовательское учреждение
- НКО / гражданское общество
- Частная компания
- Государственный орган
- Физическое лицо
Требования и условия
Показать требования из источника · Исходный текст донора (английский)
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"